Literature DB >> 19679603

Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes.

E Calabrò1, G Randi, C La Vecchia, N Sverzellati, A Marchianò, M Villani, M Zompatori, R Cassandro, S Harari, U Pastorino.   

Abstract

The relationship between smoking, lung cancer and airflow obstruction is recognised but it is unclear whether the presence of minimal lung function damage constitutes an independent risk factor for the development of lung cancer. In order to identify those individuals at higher risk of lung cancer on the basis of functional impairment, we evaluated baseline pulmonary function tests of 3,806 heavy smokers undergoing annual chest computed tomography screening, and compared the forced expiratory volume in 1 s (FEV(1)) % predicted of 57 lung cancer cases and that of 3,749 subjects without cancer. We obtained odds ratios (ORs) of lung cancer and the corresponding 95% confidence intervals (CIs) using unconditional logistic regression, adjusting for age, sex, study and smoking variables. Compared with subjects with FEV(1) >or=90% pred, the OR of lung cancer was 2.45 (95% CI 1.39-4.33) for subjects with FEV(1) <90% pred and 2.90 (95% CI 1.34-6.27) for subjects with FEV(1) <70% pred. These data show that even a relatively small reduction in FEV(1) % pred is a significant predictor of increased lung cancer risk. Test screening for lung cancer using airflow obstruction with FEV(1) <90% is a strategy worth future consideration.

Entities:  

Mesh:

Year:  2009        PMID: 19679603     DOI: 10.1183/09031936.00049909

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  28 in total

Review 1.  Screening for lung cancer using low-dose spiral CT: 10 years later, state of the art.

Authors:  M Zompatori; M Mascalchi; F Ciccarese; N Sverzellati; U Pastorino
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

2.  Improving CT screening for lung cancer with a highly predictive risk model.

Authors:  Cristiano Rampinelli; Marta Minotti
Journal:  Ann Transl Med       Date:  2018-04

3.  Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.

Authors:  Raewyn J Hopkins; Fenghai Duan; Caroline Chiles; Erin M Greco; Greg D Gamble; Denise Aberle; Robert P Young
Journal:  Ann Am Thorac Soc       Date:  2017-03

4.  Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients.

Authors:  Gina Lee; Brian K Gardner; David A Elashoff; Colleen M Purcell; Harpavan S Sandha; Jenny T Mao; Kostyantyn Krysan; Jay M Lee; Steven M Dubinett
Journal:  Am J Transl Res       Date:  2011-04-02       Impact factor: 4.060

Review 5.  Chronic obstructive pulmonary disease (COPD) and lung cancer screening.

Authors:  Robert P Young; Raewyn J Hopkins
Journal:  Transl Lung Cancer Res       Date:  2018-06

6.  Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment.

Authors:  Yan Li; Stephen J Swensen; Leman Günbey Karabekmez; Randolph S Marks; Shawn M Stoddard; Ruoxiang Jiang; Joel B Worra; Fang Zhang; David E Midthun; Mariza de Andrade; Yong Song; Ping Yang
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-30

Review 7.  What to do when a smoker's CT scan is "normal"?: Implications for lung cancer screening.

Authors:  Joanna H Zurawska; Rachel Jen; Stephen Lam; Harvey O Coxson; Jonathon Leipsic; Don D Sin
Journal:  Chest       Date:  2012-05       Impact factor: 9.410

8.  Multi-scale models of lung fibrosis.

Authors:  Julie Leonard-Duke; Stephanie Evans; Riley T Hannan; Thomas H Barker; Jason H T Bates; Catherine A Bonham; Bethany B Moore; Denise E Kirschner; Shayn M Peirce
Journal:  Matrix Biol       Date:  2020-05-11       Impact factor: 11.583

Review 9.  Lung cancer screening in patients with chronic obstructive pulmonary disease.

Authors:  Jessica Gonzalez; Marta Marín; Pablo Sánchez-Salcedo; Javier J Zulueta
Journal:  Ann Transl Med       Date:  2016-04

10.  Six minute walking test and carbon monoxide diffusing capacity for non-small cell lung cancer: easy performed tests in every day practice.

Authors:  Paul Zarogoulidis; Theodora Kerenidi; Haidong Huang; Theodoros Kontakiotis; Ourania Tremma; Konstantinos Porpodis; Anastasios Kalianos; Ageliki Rapti; Christoforos Foroulis; Athanasios Zissimopoulos; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.